Bottom line
What does ARKG hold?
ARKG held 33 positions as of Jul 31, 2026. Its largest holding is 10x Genomics Inc at 9.39% of the fund, and the top 10 positions add up to 59.1%. By asset type it is 100% stocks, 0% cash & short-term funds.
Updated Sep 22, 2026
ARKG top 25 holdings
| # | Holding | Type | % of fund | Value |
|---|---|---|---|---|
| 1 | 10x Genomics Inc TXG 10X GENOMICS INC CL A COM |
Stocks | 9.39% | $146.3M |
| 2 | Twist Bioscience Corp TWST TWIST BIOSCIENCE CORP COM |
Stocks | 7.73% | $120.4M |
| 3 | Tempus Ai Inc TEM TEMPUS AI INC CL A |
Stocks | 6.56% | $102.2M |
| 4 | Crispr Therapeutics Ag CRSP CRISPR THERAPEUTICS AG NAMEN AKT |
Stocks | 6.29% | $97.9M |
| 5 | Personalis Inc PSNL PERSONALIS INC COM |
Stocks | 5.47% | $85.3M |
| 6 | Absci Corp ABSI ABSCI CORP COM |
Stocks | 5.14% | $80.0M |
| 7 | Guardant Health Inc GH GUARDANT HEALTH INC COM |
Stocks | 4.74% | $73.8M |
| 8 | Illumina Inc ILMN ILLUMINA INC COM |
Stocks | 4.74% | $73.8M |
| 9 | Eli Lilly & Company LLY ELI LILLY & COMPANY COM |
Stocks | 4.68% | $73.0M |
| 10 | Caredx Inc CDNA CAREDX INC COM |
Stocks | 4.30% | $66.9M |
| 11 | Natera Inc NTRA NATERA INC COM |
Stocks | 4.13% | $64.3M |
| 12 | Beam Therapeutics Inc BEAM BEAM THERAPEUTICS INC COM |
Stocks | 3.78% | $58.8M |
| 13 | Compass Pathways Plc CMPS COMPASS PATHWAYS PLC SPONSORED ADS |
Stocks | 3.25% | $50.7M |
| 14 | Recursion Pharmaceuticals Inc RXRX RECURSION PHARMACEUTICALS INC CL A |
Stocks | 2.63% | $40.9M |
| 15 | Adaptive Biotechnologies Corp ADPT ADAPTIVE BIOTECHNOLOGIES CORP COM |
Stocks | 2.57% | $40.1M |
| 16 | Veracyte Inc VCYT VERACYTE INC COM |
Stocks | 2.55% | $39.7M |
| 17 | Nurix Therapeutics Inc NRIX NURIX THERAPEUTICS INC COM |
Stocks | 2.51% | $39.0M |
| 18 | Butterfly Network Inc BFLY BUTTERFLY NETWORK INC COM CL A |
Stocks | 2.18% | $33.9M |
| 19 | Schrodinger Inc SDGR SCHRODINGER INC COM |
Stocks | 1.99% | $30.9M |
| 20 | Genedx Holdings Corp WGS GENEDX HOLDINGS CORP COM CL A |
Stocks | 1.87% | $29.1M |
| 21 | Intellia Therapeutics Inc NTLA INTELLIA THERAPEUTICS INC COM |
Stocks | 1.83% | $28.5M |
| 22 | Ionis Pharmaceuticals Inc IONS IONIS PHARMACEUTICALS INC COM |
Stocks | 1.77% | $27.5M |
| 23 | Alamar Biosciences Inc ALMR ALAMAR BIOSCIENCES INC COMMON STOCK |
Stocks | 1.56% | $24.3M |
| 24 | Prime Medicine Inc PRME PRIME MEDICINE INC COM |
Stocks | 1.41% | $21.9M |
| 25 | Generate Biomedicines Inc GENB GENERATE BIOMEDICINES INC COM SHS |
Stocks | 1.11% | $17.3M |
Source: SEC Form N-PORT, period ended Jul 31, 2026, filed Sep 22, 2026